Date of event
Continuing Education Credits
Note: This webinar will be presented in Spanish only. / Este seminario web se presentará solo en español.
- Wellington Andraus, MD, PhD São Paulo University School of Medicine São Paulo, Brazil
- Marco Arrese, MD, FACP, FAASLD Pontificia Universidad Catolica de Chile School of Medicine Santiago, Chile
- Guadalupe Garcia-Tsao, MD, FAASLD Yale School of Medicine | Veterans Administration-Connecticut Health Care System West Haven, Connecticut, United States
- Manuel Mendizabal, MD Hospital Universitario Austral Buenos Aires, Argentina
- Marcelo Silva, MD Hospital Universitario Austral Buenos Aires, Argentina
- Hugo E. Vargas, MD, FAASLD Mayo Clinic Phoenix, Arizona, United States
- Fernando A. Contreras, MD Director, Department of Gastroenterology Centro de Gastroenterología Avanzada Santo Domingo, Dominican Republic
- Fernanda González-Lara, MD, MSc Infectious Diseases Specialist Clinical Microbiology Laboratory Instituto Nacional de Ciencias Médicas y Nutricion "Salvador Zubiran" Mexico City, Mexico
- Mauricio Lisker-Melman, MD, FAASLD Washington University School of Medicine St. Louis, Missouri, United States
- P. Martin Padilla, MD, PhD Professor of Medicine Universidad Nacional Mayor de San Marcos, School of Medicine Chief of Transplant Department Guillermo Almenara National Hospital Lima, Perú
- Marcus Pereira MD, MPH Columbia University Medical Center New York City, New York, United States
- Mário Guimarães Pessoa, MD Division of Gastroenterology and Hepatology University of São Paulo School of Medicine – USP São Paulo, Brazil
- Emilia Vera, MD, MSc Professor of Gastroenterology at Universidad de Guayaquil Internist-Gastroenterologist Hospital Regional Teodoro Maldonado Carbo IESS Guayaquil, Ecuador
- Elizabeth C. Verna, MD, MS Columbia University Medical Center New York City, New York, United States
As the COVID-19 pandemic continues to evolve, AASLD and the Latin American Association for the Study of the Liver (ALEH) chose to collaborate in helping our members throughout North, Central, and South America and the Caribbean, and the broader community, respond to increasing challenges and complexities.
AASLD and ALEH jointly offered a COVID-19 webinar in Spanish on May 28, 2020. This webinar provided attendees with information on the impact of COVID-19 on liver disease and transplantation in the Americas and the latest on COVID-19 management strategies related to the care of patients with chronic liver disease and pre- and post-transplantation. Faculty shared strategies surrounding re-entry and the re-opening of clinics and hospitals for patients with liver disease.
Wellington Andraus, MD, PhD
Dr. Andraus earned his Medical Degree in 1996 and completed his Residency in General Surgery, University of São Paulo (1997-1999) and his Residency in Digestive Surgery, University of São Paulo (1999-2001). He earned his Specialist Degree in Digestive Surgery from the Brazilian College of Digestive Surgery (2000). He served as Chief Resident, HCFMUSP (2001), was certified for Oncologic Surgery by the Brazilian College of Digestive Surgery (2002), and completed his Master's Degree in Medicine, University of São Paulo (2003); Fellowship in Hepatobiliary Surgery at Hôpital Beaujon, Paris, France (2006-2007); PhD in Medicine, University of São Paulo (2007). He completed a Fellowship in Living Donor Liver Transplantation at the ASAN MEDICAL CENTER in Seoul, South Korea (2008). He became an Affiliated Professor, ABC Medical School in São Paulo, Professor of the Department of Gastroenterology, FMUSP (2013). Dr. Andraus has been a transplant surgeon (since 2001) and Coordinator of Liver Transplantation Service (since 2014), Hospital das Clínicas of the University of São Paulo - HCFMUSP. He has 107 published papers in the field.
Marco Arrese, MD, FACP, FAASLD
Dr. Arrese is Professor of Medicine and Head of the Department of Gastroenterology at Pontificia Universidad Catolica de Chile School of Medicine in Santiago, Chile. Trained in Chile and the U.S. he is an expert in liver diseases and have focused his research activities in both cholestatic and fatty liver diseases. He is currently is fellow of the American College of Physicians (FACP) and the American Association for the Study of Liver Diseases (FAASLD) as well as member of the European Association for the Study of the Liver (EASL) and of the Latin American Association for the Study of the Liver (ALEH).
Guadalupe Garcia-Tsao, MD, FAASLD
Dr. Garcia-Tsao is Professor of Medicine in the Section of Digestive Diseases at Yale School of Medicine and the Chief of the Section of Digestive Diseases at the Veterans Administration-Connecticut Health Care System. Dr. Garcia-Tsao is a leading expert on portal hypertension and related complications of cirrhosis. She has over 130 PubMed-verified original publications in peer-reviewed journals that have been cited over 30,000 times and with an H-index of 79. Dr. Garcia-Tsao served as the President of the American Association for the Study of Liver Diseases (AASLD) in 2012 and as Associate Editor of HEPATOLOGY from 2011-2016. She is currently Associate Editor for the New England Journal of Medicine.
Manuel Mendizabal, MD
Dr. Mendizabal currently works as a hepatologist at the Hepatology and Liver Transplantation Unit of the Austral University Hospital in Buenos Aires. He received his medical degree from Austral University and completed his Internal Medicine residency at the same Institution. He subsequently completed his training in Hepatology and Liver Transplantation at the University of Pennsylvania under the direction of Dr. Rajender Reddy. He is part of the different regional scientific societies, being the Coordinator of the ALEH Commission of Young Investigators and is currently the Secretary of the Argentine Association for the Study of Liver Diseases (AAEEH). His areas of interest are viral hepatitis, acute liver failure, and liver transplantation.
Marcelo Silva, MD
Graduated with honours at the University of Buenos Aires School of Medicine. Completed his Hepatology training with a Fellowship at the Center for Liver Diseases and Assistant Professor of Clinical Medicine of the University of Miami School of Medicine. After returning home he became AAEEH President (Asociación Argentina para el Estudio de Enfermedades Hepáticas). He published more than 100 full papers in peer review journals, most of them in viral hepatitis field. He has been involved in the WHO STAC Viral hepatitis Committee as a member and is ALEH´s current Vice President (Asociación Latinoamericana para el Estudio de Enfermedades Hepáticas).
Hugo E. Vargas, MD, FAASLD
Dr. Vargas is a Mayo Clinic Consultant in the Department of Gastroenterology and Hepatology and the Mayo Clinic Transplantation Center. He is the Medical Director for the Office of Clinical Research – Arizona, and a Professor of Medicine in the Mayo Clinic Alix School of Medicine. Dr. Vargas is the Chair of the Clinical Research Subcommittee, and the Vice Chair of the Arizona Research Operations Management Team. Dr. Vargas has authored or coauthored more than 125 peer-reviewed articles. He is a Fellow of the AASLD, AGA, ACG, ASGE and ACP. He has been active in AASLD and has chaired the Annual Meeting Education Committee, Ethics Commitee and co-chaired the AASLD/IDSA HCV group from 2016-18.